On the contrary, patients with low levels of CD161 expression associated with shorter OS in ACC, Breast invasive carcinoma (BRCA), BLCA, CESC, Cholangiocarcinoma (CHOL), KIRC, HNSC, KIRP, LUAD, LIHC, Mesothelioma (MESO), PAAD, OV, READ, Pheochromocytoma and Paraganglioma (PCPG), PRAD, Sarcoma (SARC), Uterine Corpus Endometrial Carcinoma (UCEC), SKCM, Thyroid carcinoma (THCA, Figures 2A, B, S1). The gene discussed is KLRB1; the disease is thyroid gland carcinoma.